Amikacin – Injection Products

Recognized Interpretive Criteria
FDA Identified Interpretive Criteria

	Minimum Inhibitory Concentrations (mcg/mL)			Disk Diffusion (zone diameter in mm)
Pathogen	S	I	R	S	I	R
Enterobacterales	≤ 16	32	≥ 64	≥ 17	15 – 16	≤ 14
Pseudomonas aeruginosa	≤ 16	32	≥ 64	≥ 17	15 – 16	≤ 14
Acinetobacter spp.	M100 standard is recognized
Other non-Enterobacterales	M100 standard is recognized			-	-	-
Staphylococcus aureus	≤ 16	32	≥ 64	≥ 17	15-16	≤ 14

S = Susceptible; I = Intermediate; R = Resistant